Nabriva Therapeutics plc (NASDAQ: NBRV) today announced the pricing of its underwritten public offering of 9,411,765 ordinary shares at a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE